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Inheritedretinaldegenerations,collectivelytermedretinitispigmentosa(RP),constituteoneoftheleadingcausesofblindnessin
thedeveloped world.RPis atpresentuntreatableandthe underlyingneurodegenerativemechanismsareunknown,eventhough
the genetic causes are often established. Acetylation and deacetylation of histones, carried out by histone acetyltransferases
(HATs) and histone deacetylases (HDACs), respectively, affects cellular division, differentiation, death and survival. We found
acetylation of histones and probably other proteins to be dramatically reduced in degenerating photoreceptors in the rd1 human
homologous mouse model for RP. Using a custom developed in situ HDAC activity assay, we show that overactivation of HDAC
classes I/II temporally precedes photoreceptor degeneration. Moreover, pharmacological inhibition of HDACs I/II activity in rd1
organotypic retinal explants decreased activity of poly-ADP-ribose-polymerase and strongly reduced photoreceptor cell death.
These ﬁndings highlight the importance of protein acetylation for photoreceptor cell death and survival and propose certain
HDAC classes as novel targets for the pharmacological intervention in RP.
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Retinitis pigmentosa (RP) is a group of inherited neurode-
generativediseases that result in selectivecell death of retinal
photoreceptors. Usually the mutations ﬁrst lead to degenera-
tion of the rod photoreceptor cells followed by a mutation-
independent secondary degeneration of cone photorecep-
tors. With a prevalence of about 1:3500, RP is considered as
the main cause of blindness among the working age
population in the developed world. At least 40 RP causing
mutations have been identiﬁed so far, but the metabolic
pathways leading to photoreceptor cell death have not been
resolved, and no adequate RP treatment is available.
1
The rd1 mouse is one of the most studied human
homologous RP animal models and carries a loss-of-function
mutation in the gene encoding for the b-subunit of rod
photoreceptor cGMP phosphodiesterase-6.
2 This leads to
an accumulation of cGMP, which eventually causes photo-
receptor cell death.
3,4 In microarray experiments, we and
others found rd1 degeneration to be accompanied by
extensive changes in gene expression.
5–7 Although some
changes may result from direct and speciﬁc effects of cGMP
on deﬁned genes,
8 it is likely that also more generalized
alterations of the transcriptional machinery are involved.
Previously, we have shown that rd1 photoreceptor degenera-
tion is in part caused by a strong activation of poly-ADP-
ribose-polymerase (PARP),
9 which may have a bearing on
transcriptional activity.
10 However, as PARP activity was
found to occur only relatively late during rd1 degeneration, we
hypothesized that there might be yet other mechanisms
causing dysregulation of gene expression.
Gene regulation is to a large extent governed by epigenetic
mechanisms, among which acetylation of histones
11 appears
to be one of the most important.
12 Histone acetylation and
deacetylation is mediated by histone acetyltransferases
(HATs) and histone deacetylases (HDACs), respectively.
13
The HDAC family is subdivided into three main classes
(HDAC I, II, and III), depending on their similarity with
homologous yeast genes. Class I (HDAC 1–3 and 8) and
class II (HDAC 4–7, 9, and 10) are inhibited by trichostatin A
(TSA).
13 Class III HDACs, also referred to as sirtuins
(isoforms: sirt1–7) form a structurally distinct class of
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þ-dependent enzymes that can be inhibited by nicotina-
mide (NAM).
14
Although a number of studies have related transcription of
photoreceptor genes and photoreceptor viability with histone
acetylation,
15–17 information regarding whether and how
HDAC activity connects to degenerating photoreceptors is
lacking. Here, we analyzed enzymatic activities of different
HDAC classes in situ on retinal tissue sections and studied
how various inhibitors affect retinal cell viability. Activity of
HDACs I/II was strongly elevated in rd1 photoreceptors and
causally related to their death, suggesting HDAC inhibition as
a novel approach for neuroprotection in retinal degeneration.
Results
Expression of HDACs in wt and rd1 retina. Microarray
analysis of the expression of 13 different HDAC genes did
not identify any signiﬁcant differences between wild type (wt)
and rd1 (Figure 1a). Immunohistology revealed that HDACs
representing all three major classes were present in wt and
rd1 retina at post-natal day (P) 11. Both class I HDAC2
(Figure 1a, d) and class II HDAC5 (Figure 1b, e) were
prominently expressed in nuclei of the outer nuclear layer
(ONL), inner nuclear layer (INL), and ganglion cell layer. In
contrast, class III HDAC Sirt2 (Figure 1c, f) was expressed
predominantly in non-nuclear structures including
photoreceptor segments, neuritic processes in the ONL,
and different INL cells. No obvious differences in expression
or localization between wt and rd1 at P11 were detected for
any of the HDACs.
rd1 photoreceptor nuclei show hypoacetylation. Acetylation
of lysine residues was studied in wt and rd1 retinae using
acetylation-speciﬁc antibodies (Abs). In the ONL of wt mice at
P11, an Ab detecting general acetylation of lysine residues
showed homogeneous staining of the photoreceptor population
(Figure 2a-c). In contrast, the P11 rd1 ONL presented staining
‘gaps’ that contained unlabeled photoreceptor nuclei (Figure
2d-f). Such lack of staining encompassed decreased histone
acetylation, as conﬁrmed by several Abs directed against
speciﬁc acetylated histones (Supplementary Figure 1). No
obvious signs for hypoacetylation for any of the Abs used were
found in the inner retina of neither wt nor rd1. Western blot (WB)
of P11 in vivo retinae with the acetyl-lysine Ab (Figure 2g) mainly
revealed bands between 12 and 17kDa that corresponded to the
reported molecular weights of different histones and showed
numerically decreased acetylation levels in the rd1 retina (wt:
100%; rd1: 89.8%±40, n¼3).
HDAC activity is increased in rd1 photoreceptors. To
investigate whether the decreased rd1 photoreceptor
acetylation was related to increased activity of HDACs, we
adapted a technique originally intended to measure tissue
homogenates
18 for the use on retinal tissue sections.
Whole ﬁxed retinal cryosections revealed deacetylation
activity. By speciﬁcally blocking either HDACs I/II with TSA or
HDAC III with NAM, we were able to distinguish the relative
contributionsofdifferentclassesofHDACstothetotalactivity,
and to follow their kinetics with different substrate concentra-
tions.AsproofofprinciplefortheHDACassay,wedetermined
the Km values for total HDAC activity on retinae of rd1 and wt
mice (Supplementary Figure 2). The Km value for the
ﬂuorogenic substrate of 83mMa t5 0 0 mM NAD
þ is in good
agreement with previous reports.
19 When studied with cellular
resolution, both wt and rd1 tissue displayed HDAC activity in
photoreceptor segments. All nuclear layers of wt retina were
essentially devoid of visible activity (Figure 3a). In contrast,
the rd1 ONL carried a subset of cells, displaying typical
nuclear morphology of photoreceptors, with highly elevated
HDAC activity (Figure 3b). Inhibition of either class I/II HDACs
(Figure 3c) or HDAC III (Figure 3d) suggested that most of the
excessive HDAC activity in rd1 photoreceptor originated from
HDAC I/II. Together, these results implied that rd1 photo-
receptor hypoacetylation was due to an excessive activation
of HDACs, and most likely HDAC I/II.
HDAC activity and cell death. To test whether the high
HDAC activity observed in rd1 photoreceptors was related to
Figure1 Micro-arrayanalysisandimmunodetectionofdifferentHDACisoforms
in wt and rd1 retinae at P11 in vivo. mRNA expression for 14 different HDAC
isoforms pertaining to all four HDAC classes was assessed using micro-array
analysis. (a) For all studied HDAC isoforms, the ratio of mRNA expression wt/rd1
was not signiﬁcantly different from 1, indicating that expression was not changed.
Values are mean±SEM from ﬁve independent hybridization experiments, each
containing retinae from four male wt and four rd1 animals. Immunostaining was
performed for three different HDAC isoforms representing HDAC classes I–III.
HDAC2(b,e)andHDAC5(c,f)wereexpressedinthenucleiofONL,INL,andGCL,
while Sirt2 (d, g) was expressed in photoreceptor segments and neuritic processes
intheONLanddifferentINLcelltypes.Noobviousdifferencesbetweenwt(b-d)and
rd1 (e-g) were found. Scale bar: 50 mm
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Cell Death and Diseasetheir degeneration, staining for acetylated lysine was
combined with the TUNEL assay for dying cells. Most of
the cells lacking acetylation (94.3%±7.3 S.E.M., n¼3) were
also TUNEL positive (Figure 4a–c). In another co-labeling
experiment, rd1 HDAC activity colocalized only partially
(32.5%±6.7 S.E.M., n¼3) with TUNEL-positive cells
(Figure 4d–f) implying that the activity generally preceded
the ﬁnal stages of cell death. To conﬁrm this hypothesis, we
assessed the number of HDAC activity positive cells in the
ONL of wt and rd1 retinas at various time points during the
second post-natal week (i.e., during onset and peak of rd1
degeneration). The analysis of the temporal progression of
HDAC activity showed a marked increase in the number
of HDAC activity positive cells at P9, with a peak in
activity already at P11 (Figure 4g). Comparison with
previously published data on cell death (TUNEL assay) and
PARP activity
9 indicated that the peak in HDAC activity
preceded the peak of the degeneration by B2 days. Overall,
this suggested that an acetylation/deacetylation imbalance
might have an important role in rd1 photoreceptor
degeneration.
HDAC I/II inhibitors protect rd1 photoreceptors. We then
exposed retinal explants in a short-term culture paradigm
(until P11) to inhibitors speciﬁc for the three main classes of
HDACs and evaluated the outcome on photoreceptor viability
using the TUNEL assay.
The HDAC I/II inhibitor TSA (1mM) did not affect the
number of TUNEL-positive cells in the ONL of P11 wt retinal
cultures (TSA: 1.6±0.2%, n¼6 retinal cultures from six
different animals versus vehicle controls: 1.7±0.2%, n¼9;
Figure 5a, b). In the rd1 retina, however, 1mM TSA signi-
ﬁcantly decreased the rate of cell death (TSA: 2.2±0.4%,
n¼12 versus vehicle: 3.5±0.2%, n¼27, Po0.001; Figure 5c, d;
quantiﬁcation in panel e). A second HDAC I/II inhibitor,
Scriptaid (6mM), also conferred a signiﬁcant neuroprotective
effect to rd1 photoreceptors (Scriptaid: 2.6±0.1%, n¼6,
versus vehicle: 3.5±0.2%, n¼27, Po0.05). The HDAC III
inhibitor NAM (200mM and 1mM) had no measurable effect
on photoreceptor viability (NAM 200mM: 3.9±0.2%, n¼5
versus vehicle: 3.5±0.2%, n¼27; Figure 5e). Neither of the
above treatments affected the number of photoreceptor rows
(quantiﬁcation in Figure 5e). Successful in vitro HDAC
Figure 2 Decreased acetylation in rd1 photoreceptors in vivo. At P11 immunoﬂuorescence for acetylated lysine residues (green) on wt (a) and rd1 (d) retinae revealed a
number of DAPI-stained rd1 photoreceptor nuclei (b, e; blue) with very low levels of protein acetylation. (Merged pictures in c, f, arrowheads indicate nuclei showing low
acetylation levels.) WB with the same Ab mainly labeled bands corresponding to the molecular weight of histones (g). Scale bar: 20 mm
Figure 3 HDAC activity in the retina in vivo. HDAC activity was detected in situ in particular in the segment layers of both wt (a) and rd1 (b) retina. In contrast to wt, rd1
retinadisplayedasubsetofONLcellswithstronglyincreasedHDACactivity.ActivityofHDACI/II(c)wasstudiedbyinhibitionofHDACIIIwithNAM.Conversely,sirtuinactivity
(d) was assessed by inhibiting HDACs I/II with TSA. Combined inhibition with TSA and NAM was used as negative control (e). Scale bar: 50 mm
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Cell Death and Diseaseinhibition by TSA was conﬁrmed using both a tissue-based
analysis (WB for acetylated lysine; Figure 5f) and an in situ
approach (HDAC activity; Supplementary Figure 3).
AlthoughwedidnotobserveanynegativepropertiesofTSA
in our cultures, a previous study on acute wt retinal explants
showed proapoptotic effects of TSA at early developmental
stages.
16 To address the possibility of a transient TSA effect
on retinal cell viability, we treated P5 rd1 retinal explants with
1mM TSA for 24h, but this did not affect the percentage of
TUNEL-positivecellsintheP6invitroretina(TSA:1.7±0.2%,
vehicle: 1.5±0.3%; n¼3; Supplementary Figure 4). Further-
more, when extending the culture period for another 5 days
without TSA (P5þ1þ5¼P11), to match with the end point
used in our previous experiments, the treated rd1 retina again
showed a markedly reduced number of TUNEL-positive cells
(TSA: 1.0±0.2%; vehicle: 3.8±0.5%, n¼3, Po0.05). At the
same time, the number of photoreceptor rows was not
signiﬁcantlyaffectedbythetreatment(TSA:7.1±0.2,vehicle:
7.5±0.1; n¼3).
To test whether the strong neuroprotective effect of TSA in
the different short-term paradigms would translate into
improved long-term survival of photoreceptors, in vitro
treatment was prolonged until P28. TSA treatment almost
doubled the number of surviving rd1 photoreceptor rows
(TSA: 4.1±0.3; vehicle: 2.1±0.2, n¼6, Po0.001; Figure 5i).
Expressionofrhodopsinwasthenanalyzedasanindication
of rod photoreceptor identity. In wt retina, in vivo rhodopsin
expression is restricted to the outer segments of rod
photoreceptors, whereas in rd1 retina, where outer segments
do not develop properly, it is partly mislocalized and also
observed throughout the cytoplasm of photoreceptors.
20 This
phenomenon intensiﬁes under in vitro conditions where
Figure 4 ProteinacetylationandtemporalprogressionofHDACactivityandcelldeathinvivo.AtP11,immunostainingforacetylatedlysineresidues(a,green)inrd1ONL
showed characteristic ‘‘gaps’’, which were partly ﬁlled by TUNEL staining (red) for dying cells (b) (merged in c), suggesting hypoacetylation to contribute to photoreceptor cell
death. Conversely, the HDAC activity assay (d, f) colocalized in part with TUNEL staining at P11 (e) in the rd1 ONL (merged in f). Scale bar: 20mM. The graph in g shows the
temporalprogressionofHDACactivity(blueline)inwtandrd1ONLduringthesecondpostnatalweek,andrelatesittothetime-courseforTUNEL-positivecells(red).Notethat
thepeakof HDACactivitymarkedlyprecedesthepeakofTUNEL.nX3for eachtimepointandgenotype,dataforTUNELassaywerepreviouslypublishedinPaquet-Durand
et al., 2007 and are shown here for reference purposes only
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Cell Death and Diseaserhodopsin mislocalization is observed in both wt and rd1
photoreceptors (Supplementary Figure 5). In long-term TSA-
treated explants, rhodopsin expression was found in most of the
surviving rd1 photoreceptors, whereas in the untreated situation
most remaining ONL cells were rhodopsin negative and most
likely predominantly cones (Figure 5g, h). Signiﬁcantly, rhodop-
sin-positive photoreceptor outer segments were observed in
TSA-treated specimens, when at the same time in the untreated
situation, outer segments were completely absent. This sup-
ported the idea that TSA indeed upheld survival of rod
photoreceptors and promoted growth of rd1 outer segments.
All in all, TSA treatment in both short- and long-term retinal
culture demonstrated a strong prosurvival effect, whereas
NAM had no such protective effects. The experiments
therefore suggested a major contribution of HDAC I/II, but
not III, to mutation-induced rd1 photoreceptor death.
HDAC I/II regulate PARP activity. As we had previously
found PARP activity to be involved in rd1 photoreceptor cell
death,
9 we wanted to investigate a possible interaction
between HDACs and PARP. When immunostainings for
acetylated lysines and for poly-ADP-ribose (PAR) – the
product of PARP activity – were combined, the merged
images revealed PAR-positive photoreceptor nuclei
exclusively in cases where acetylation was absent (Figure
6a–d). Together with the data on the progression of HDAC
activity (Figure 4g), this suggested that hypoacetylation and
hence HDAC activity was preceding PARP activity.
We then tested whether HDAC I/II inhibition by TSA
indirectly also affected PARP activity. With respect to PAR
immunostaining, there was a moderate amount of positive
photoreceptor nuclei in wt retinal explant cultures at P11 (wt
vehicle: 0.25%±0.1, n¼3), and a comparatively muchhigher
number in rd1 explants (rd1 vehicle: 0.9%±0.1; Figure 6e, g).
The presence of PAR-positive photoreceptors in wt explants
is likely due to the stress that these undergo during culture. In
both wt and rd1 explants, the number of PAR-positive cells
was reduced by TSA treatment, and this reduction was
Figure5 HDACinhibitionreducesphotoreceptorcelldeathinvitro.Short-termretinalexplantculturesfromrd1andwtanimalswereexposedtocontrolconditionsor1mM
TSAfromP7to P11(a-d).In untreatedspecimens(a,c),TUNELassay(green)showedthecharacteristicincreaseofdyingcellsinrd1 ONLcomparedwith wt.TSAtreatment
(b, d) reduced the number of degenerating photoreceptors in rd1, but did not alter viability of wt. The bar graph (e) summarizes effects of TSA, 6 mM Scriptaid, and 200 mM
NAM on photoreceptor viability. HDAC I/II inhibitors, TSA and Scriptaid, signiﬁcantly reduced the amount of dying cells, whereas HDAC III inhibitor NAM had no effect on cell
survival. Immunoblotting for acetylated lysine residues (f) showed an increase in protein acetylation after TSA treatment in both wt and rd1 retinae. Long-term cultures of rd1
retinae (until P28; g, h) treated with TSA showed a marked increase in the number of rhodopsin-positive cell bodies and overall size of their ONL when compared with
untreatedsituation(quantiﬁcationini).DAPI(blue)wasusedasnuclearcounterstain;actinimmunoblottingwasusedasloadingcontrolinf;nX6,Scalebarsindandhare50
and 20 mM respectively
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Cell Death and Diseasestatistically signiﬁcant in the rd1 situation (rd1 TSA:
0.3%±0.2, n¼3, Po0.05; Figure 6f, h). These results
supported the notion that activation of PARP in rd1 photo-
receptors occurred downstream of HDAC I/II activity.
Discussion
The activity of HDACs has previously been connected to a
variety of different cellular processes, notably regulation of
gene expression, cytoskeletal rearrangements, division, and
differentiation.
13 Here, we show that HDAC activity was
causallyrelatedtoinheritedphotoreceptorcelldeathintherd1
mouse and that this detrimental effect was tied to HDACs I/II.
HDACs III did not seem to be involved in the degeneration,
which corresponds to observations on weakened HDAC III
action in degenerating retina.
21 The strong neuroprotection
afforded by HDAC I/II inhibitors in both short- and long-term
retinal explant cultures proposes them as novel lead
compounds to prevent or delay retinal neurodegeneration.
HDAC and gene regulation. Given the extensive effects of
acetylation/deacetylation on gene regulation, the observed
HDAC hyperactivation would likely result in signiﬁcantly altered
rd1 gene transcription, which matches with previous
microarray data.
5–7 On the other hand, we can at present not
exclude the possibility that the observed histone deacetylation
was due in part also to a decreased activity of HATs. Our
observations that rd1 gene alterations include downregulation
of the transcription factor CREB
6,8,22 is of particular interest
here, as CREB not only appears to confer neuroprotection
6,8,22
but also has several links to cellular acetylation events. For
example, different HDAC I/II isoforms can recruit protein
phosphatase-1 to dephosphorylate and inactivate CREB,
23
which might be related to its downregulation in the rd1 retina.
Moreover, CREB target gene transcription is facilitated by its
co-factor CREB-binding protein (CBP), which has HAT
activity,
24 and therefore connects CREB activation with
histone acetylation. Accordingly, some of the effects on
neuronal gene regulation seen when acetylation is increased
by HDAC inhibition may be routed through enhanced activity of
CREB and CBP.
25 The expression of opsin and other
photoreceptor genes is controlled by the photoreceptor-
speciﬁc transcription factor cone-rod-homeobox (CRX).
26 In
conjunction with histone acetylation and CBP, CRX drives
expression of these critical photoreceptor genes in Y79
retinoblastoma cells and in the mouse retina.
15,27
Figure6 HDACandPARPactivitiesareconnected.Inrd1P11invivospecimens,asubsetofONLnucleishowedunusualchromatincondensationasevidencedbyDAPI
nuclear counterstain (a, blue). In most of these cells a strong accumulation of poly-ADP-ribose (PAR) (b, red) colocalized with hypoacetylation (c, green; merged in d; white
arrowheads), suggesting a functional connection between acetylation and PARP activity. In short-term retinal explant cultures at P11, photoreceptors showing PAR
accumulation were observed in untreated wt (e) and rd1 retina (g), their number being much higher in the latter case. This number was strongly reduced by TSA treatment in
bothwt(f)andrd1retina(h;quantiﬁcationini),implyingthatactivationofPARPoccurreddownstreamofHDACI/IIactivity.n¼3;Scalebarind,h¼20mM.SomeofthePAR
immunostaining between ONL and INL relates to IGG staining in blood vessels
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Cell Death and DiseaseCross-talk between HDAC and PARP activity. PARP
activity is involved in DNA damage repair and hence often
seen as a benign factor, although excessive PARP activity may
compromise cellular viability.
10 Increased PARP activity, as
seen in rd1 photoreceptors,
9 consumes NAD
þ and generates
NAM, which in turn negatively regulates HDAC III activity and
thereby favors acetylation of its target proteins.
14 As HDAC III-
dependent deacetylation of the automodiﬁcation domain of
PARP blocks its activity,
28 low NAD
þ levels could trigger a
positive feedback loop accounting for both the high PARP
activity and the low HDAC III activity observed in rd1
photoreceptors. Yet other reports demonstrate that
acetylation by p300/CBP promotes the ability of PARP-1 to
act as a co-activator in transcription
30, whereas acetylation by
histone acetyltransferases PCAF and GCN5L reduces PARP-2
catalytic activity.
29,30 The ﬁndings highlight a possibility for
hyperactive HDAC I/II to intervene with various PARP types,
perhaps causing abnormal stimulation of these enzymes. In
such a scheme, HDAC I/II activity would be upstream of PARP
activation in rd1 photoreceptor degeneration, which is in accord
with our results, where TSA treatment reduced accumulation of
PAR. In addition, PARP activity accompanies the event of
dying, TUNEL-positive photoreceptors and colocalizes to a
large extent with them,
9 whereas in this study, TUNEL
colocalization with HDAC activity was only minor. This again
implies that HDAC activity was upstream of PARP activation.
HDAC activity in cell death and survival. Experimental
evidence suggests that both overactivation of HDACs I/II or
their inhibition promotes cell death.
13 Similarly, HDAC III activity
can have both pro- and antiapoptotic effects depending on cell
type and proliferation state,
31 and the right balance between the
activities of different HDAC classes therefore seems to be
crucial for maintaining cellular viability.
13 In addition, individual
members of each HDAC class could have distinct cell type-
speciﬁc roles,
32 perhaps related to their expression levels,
which may in part explain the opposing effects of HDAC
inhibitors observed in different neurodegeneration paradigms.
12
T h ep r o t e c t i v ee f f e c t so fT S Aa n dS c r i p t a i dc o m p l yw i t ha
number of studies on post-mitotic neurons, where HDAC
inhibitors also conferred neuroprotection,
12,33,34 possibly in part
due to the prevention of oxidative stress
35 and reactivation of
CREB signaling.
36,37 Furthermore, it is conceivable that in the
rd1 situation HDAC inhibition may induce expression or
increase the stability of neuroprotective genes and proteins
that are not directly related to the pathological mechanism. In
this context, the chaperone HSP90, which is a target for HDAC-
dependent deacetylation, appears to have a prominent role in
neurodegeneration. Acetylation at its K294 residue inhibits
HSP90
38 and hence HDAC inhibitors indirectly also block
HSP90 activity.
39 Interestingly, HSP90 inhibition induces an
upregulation of the neuroprotective chaperone HSP70 and
strongly increases neuronal survival.
40,41 Our ﬁnding that
decreased histone acetylation combines with increased
HDAC activity corresponds to very similar observations made
in motorneurons in a mouse model for amyotrophic lateral
sclerosis, where HDAC inhibition also resulted in
neuroprotection.
36 In the in vivo retina, HDAC inhibition has
been shown to promote survival of ganglion cells after optic
nerve crush.
37
Conclusion
The mechanisms governing inherited photoreceptor cell
death have remained elusive to date.
1 Our discovery that
HDAC activity was involved in photoreceptor degeneration
may thus help to close a major gap of knowledge between the
immediate effects of a single gene mutation
2 and the
observed massive changes at the transcriptional level.
6
Moreover, increased HDAC activity appeared to be respon-
sible for an activation of PARP in degenerating rd1 photo-
receptors. The exact interplay between PARP and HDAC
activity warrants further studies, as it may potentially explain
crucial events in the pathological process. This study not only
brings up HDAC activity as a ‘missing link,’ uniting several
other ﬁndings on the mechanisms of photoreceptor cell death,
but also highlights HDACs as novel targets for the develop-
ment of neuroprotective therapies aimed to halt or delay
inherited retinal degeneration in humans.
Material and Methods
Animals. Animals were housed under standard white cyclic lighting, had free
access to food and water, and were used irrespective of gender. C3H rd1/rd1 (rd1)
and control C3H wt mice were used.
42 All procedures were performed
in accordance with the local ethics committee in Lund (permits M225-04 and
M242-07), the Tu ¨bingen University (y4 registration from 23–01–08), and the ARVO
statement for the use of animals in ophthalmic and visual research. All efforts were
made to minimize the number of animals used and their suffering. Because of the
criticalchangesatP11,
22,43mostcomparisonsbetweenrd1andwtwerecarriedout
at this age. Day of birth was considered as P0.
Microarrayanalyis. Details of the transcription assayperformedon a custom-
made mouse gene chip were described in Azadi et al.
6 Two times up- or
downregulation in at least three out of ﬁve hybridizations was considered as
signiﬁcant variation. Results not pertaining to this study are published elsewhere.
In vitro retinal explant cultures. Retinae from P5 rd1 and wt animals were
usedtogenerateretinalexplantsasdescribedbefore.
4,44Inbrief,animalswerekilled
andtheeyesenucleatedinanasepticenvironment.Afterwards,theentireeyeswere
incubated in R16 serum-free culture medium (Invitrogen Life Technologies, Paisley,
UK; 07490743A) containing 0.12% proteinase K (MPBiomedicals, Solon, OH, USA;
193504) at 371C for 15min, to allow preparation of retinal cultures with RPE
attached. Proteinase K was inactivated with 10% fetal calf serum (Invitrogen Life
Technologies; PET10108165) in R16 medium, and the eyes dissected aseptically in
aPetridishcontainingR16medium.Theanteriorsegment,lens,vitreous,sclera,and
choroids were carefully removed, and the retina was cut perpendicular to its edges,
resulting in a cloverleaf-like shape. Subsequently, the retina was transferred to a
Millicell culture dish ﬁlter insert (Millipore AB, Solna, Sweden; PIHA03050) with the
retinal pigment epithelium layer facing the membrane. The insert was put into a six-
wellcultureplate andincubatedin R16nutrient mediumat 371C. Everysecondday,
the full volume of nutrient medium,1.5ml per dish, was replaced with fresh medium.
The ﬁrst 2 days, the retina was left in R16 culture medium without treatment to
adapt to culture conditions. At P7, cultures were either exposed to different
treatments (TSA 1mM, Scriptaid 6mM, NAM 200mM, and 1000mM; all from Sigma,
Munich,Germany),orkeptasuntreatedcontrol.NAMisaconstituentoftheculturing
mediumandpresentatabout22mM,whichshouldbelessthanhalfthereportedIC50
value in cell-free studies.
45 Explants were cultured until P11 for short-term cultures
(P5þ2þ4), or until P28, for long-term cultures (P5þ2þ21). Culturing was
stopped by 2h ﬁxation in 4% paraformaldehyde (PFA), washed 4 15min in
phosphate-bufferedsaline(PBS),then cryoprotected ﬁrst with PBS þ10%sucrose,
and subsequently with PBS þ25% sucrose. Explants were frozen and embedded
in Jung tissue freezing medium (Leica Microsystems, Nussloch, Germany) for
cryosectioning (12mm).
HDAC assay. HDAC activity assays were performed on cryosectionsof4%PFA
P11 ﬁxed eyes. The assay is based on an adaptation of the Fluor de Lys Fluorescent
Assay System (Biomol, Hamburg, Germany). Retinal sections were exposed to
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100mM TSA (Sigma, Steinheim, Germany), 2mM NAM (Sigma), and 500mMN A D
þ
(Biomol) in assay buffer (50mM Tris/HCl, pH 8.0; 137mM NaCl; 2.7mM KCl; 1mM
MgCl2; 1mg/ml BSA) and 0.1% NP40 and 0.5  Developer II (Biomol). Images were
captured at indicated time points with a ﬁxed exposure time of 2s using a Zeiss
(Jena, Germany) Axiophot microscope ( 20 magniﬁcation) and Zeiss Axiovision 4.2
software; densitometry was performed with the aid of ImageJ (National Institutes
of Health, Bethesda, MD, USA). The reaction rate was determined in at least
four independent experiments, as the slope of the linear regression ﬁtted to the
data points in the linear range of a time course, using SigmaPlot (Systat software,
Erkrath, Germany) software. For the calculation of Km values, the slope of time
courses with different substrate concentrations was plotted against the corresponding
substrate concentrations; a hyperbolic regression ﬁtted to the data points revealed Km
values and Vmax.
In situ deacetylation activity was determined on retinal sections incubated for 3h
with 200mM Fluor de Lys-SIRT2 deacetylase substrate in assay buffer with/without
inhibitors. Sections were then washed in PBS and ﬁxed in methanol at  801C for
20min.  0.5 developer (Biomol) in assay buffer was applied and pictures taken
immediately in an Apotome microscope (Zeiss), at  20 using the DAPI ﬁlter.
TUNEL assay. The terminal deoxynucleotidyl transferase dUTP nick end
labeling (TUNEL) assay was performed on cryosections from treated and untreated
rd1 retinas, using an in situ cell death detection kit conjugated with tetra-
methyl-rhodamine or ﬂuorescein isothiocyanate (Roche Diagnostics, Mannheim,
Germany). For controls, terminal deoxynucleotidyl transferase enzyme was
either omitted from the labeling solution (negative control), or sections were
pretreated for 30min with DNAse I (Roche Diagnostics, 3U/ml) in 50mM Tris-HCl,
pH 7.5, 1mg/ml BSA to induce DNA-strand breaks (positive control). Negative
control showed no staining at all, whereas positive control stained all nuclei in all
layers of the retina.
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Immunostaining. Frozen retinal sections from P11 animals or cultured retinae
were dried for 30–60min at 371C. Subsequently, the tissue was rehydrated in PBS, and
preincubated for 1h at room temperature (RT) in blocking solution, containing 10%
normal serum, and 0.1 or 0.3% Triton in PBS (PBST). Immunohistochemistry was
performed overnight at 41C, using primary Abs (acetylated lysine; acetylated H2A, H2B,
H3, H4; Sirt2; HDAC2; HDAC5; PAR) diluted 1:100 in blocking solution. Primary
Abs were purchased from Cell Signaling (Danvers, MA, USA) except PAR Ab
(Alexis Biochemicals, Lo ¨rrach, Germany) and Rhodopsin Ab (Millipore, Schwalbach,
Germany). The tissue was rinsed with PBST, and incubated for 1h with a corresponding
secondary Ab, Alexa 488 (1:200–1:750, Invitrogen), diluted in PBST. Sections
were rinsed in PBS, and mounted in Vectashield with DAPI (Vector Laboratories,
Burlingame, CA, USA).
Western Blot. Retinae from P11 animals were enucleated and stored at
 801C. Later on, the tissue was homogenized in buffer (10mM Tris, 1mM EDTA,
150mM NaCl, 1mM Na3VO4, 50nM okadaic acid, 2% SDS, 10% glycerol, 0.0625M
Tris-HCl, and protease inhibitor cocktail 10ml/ml (Calbiochem, Darmstadt, Germany);
pH6.8)withaHeidolphDIAX600homogenizer(Heidolph,Schwabach, Germany)ora
manual homogenizer (glass to glass). Retinal explant cultures, both treated and
untreated withTSA,from wt andrd1 micewerehomogenizedusing the sameprocess.
Bradford assay was used to measure protein concentration. Proteins were then
separated by SDS-PAGE 4–12% gradient gel (at 55V), and transferred to a PVDF
membrane (Amersham Biosciences, Buckinghamshire, UK). Membranes were
incubated in Roti block (Roth, Karlsruhe, Germany) blocking buffer for 3h at RT.
After washing, primary Abs (acetylated lysine; acetylated H2A, H2B, H3, H4; actin)
were added at a dilution of 1:1000 in buffer containing TBS-T and 5% dried milk
(Roth), and incubated overnight at 41C. Primary Abs were purchased from Cell
Signaling,exceptforactinAbwhichwasfromChemicon(Schwalbach,Germany).After
washing, the membranes were treated with buffer containing HRP-conjugated
secondary Ab (Amersham Biosciences) overnight at 41C. The membranes were
developed using Hyperﬁlm (Amersham Biosciences) detection system. Quantiﬁcation
was performed after ﬁlm scanning using ImageJ (NIH).
Microscopy, cell counting, and statistics. Morphological observations
and routine light microscopy were performed on a Zeiss Imager Z1 Apotome
Microscope, equipped with a Zeiss Axiocam digital camera. Images were captured
using Zeiss Axiovision 4.7 software; image overlays and contrast enhancement
were performed using Adobe Photoshop CS3. Images shown in ﬁgures are
representative for least three different animals for each genotype/treatment.
Percentages of TUNEL-positive cells were assessed and calculated in a blinded
manner as reported previously.
4,9 The mean value for photoreceptor rows in the
ONL after in vitro culture was determined using DAPI nuclear counterstaining.
Values are given as mean±S.E.M. Statistical signiﬁcance was tested using one-
way ANOVA with Bonferroni correction and Prism (GraphPad Software, San Diego,
CA, USA), signiﬁcance levels were Po0.05 (*), Po0.01 (**), and Po0.001 (***).
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